New booster shots, antigen testing, and a shrinking incubation period: these were the top COVID-19 stories of 2022.
We are now 3 years out from the first recorded COVID-19 infection, and 2 years out from the first administered COVID-19 vaccine.
Unfortunately, COVID-19 was a mainstay in this year's news cycle. However, alongside stories of the virus mutating to become more infectious were stories of new vaccine developments to combat the latest COVID-19 variants.
These were our most-clicked COVID-19 stories in 2022.
Study finds high false positive results with one batch of a rapid antigen test for SARS-CoV-2 but "very low" overall false positive rate.
The incubation period of the original, wild-type COVID-19 strain was 6.65 days, while the Omicron variant's incubation period has shortened to 3.42 days.
Moderna’s new bivalent COVID-19 booster, which includes 25 micrograms each of messenger RNAs from the Wuhan-Hu-1 and Omicron B.1.1.529 variants of SARS-CoV-2, elicited antibody responses that were superior to those elicited by the original vaccine.
An explanation of the risks associated with COVID-19 booster shots.
A recent study broke down hospitalizations associated with COVID-19 in adults between January 2021 and April of this year, based upon vaccination status.